NCT03349281 Pevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory ALL or Lymphoblastic NHL Status COMPLETED Phase PHASE1
NCT03341676 Spectroscopic and Diffusion Weighted Analysis of the Effects of Dexamethasone on High Altitude Cerebral Oedema (HACE) Status COMPLETED Phase PHASE1
NCT03338400 Dexamethasone Administration To Improve Patient Recovery In Ambulatory Vaginal Prolapse Surgery: Is There A Role? Status COMPLETED Phase PHASE2
NCT03336073 Carfilzomib, Cyclophosphamide, Dexamethasone in Multiple Myeloma Status UNKNOWN Phase PHASE2
NCT03334487 Study Evaluating the Safety of Rovalpituzumab Tesirine for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Small Cell Lung Cancer Status WITHDRAWN Phase PHASE3
NCT03330028 Study of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology Status COMPLETED Phase PHASE1
NCT03328975 An Evaluation of Blood Glucose Levels and Insulin Requirement After Subacromial Corticosteroid Injection in Insulin Dependent Diabetics Status WITHDRAWN Phase NA
NCT03324113 Evaluation of SAR408701 in Japanese Patients With Advanced Malignant Solid Tumors Status COMPLETED Phase PHASE1
NCT03319667 A Study to Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03314636 Intensified Treatment With Carfilzomib in Myeloma Patients Still PET-positive After First Line Treatment. Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03314181 A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03311425 Effect of Local Intraoperative Steroid on Dysphagia After ACDF Status COMPLETED Phase PHASE3
NCT03290950 A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03289299 Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03287908 A Study to Assess AMG 701 Montherapy, or in Combination With Pomalidomide, With or Without, Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma Status TERMINATED Phase PHASE1
NCT03283046 Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple Myeloma Status WITHDRAWN Phase PHASE1
NCT03275285 Multinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethasone In Relapse And/Or Refractory Multiple Myeloma Patients Status COMPLETED Phase PHASE3